Boston Biomedical, Inc. logo

Boston Biomedical, Inc.

31 employees · est. 2006 · Cambridge, United States

VS
Santaris Pharma logo

Santaris Pharma

Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse disease states.

est. 2003

Santaris Pharma is the older company (2006 vs 2003).

Side-by-Side Comparison

Boston Biomedical, Inc. Santaris Pharma
Founded
2006 2003 older
Headquarters
Cambridge, United States Not tracked yet
Employees
31 Not tracked yet
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series Unknown Series Unknown
Total Funding
Not tracked yet $72.40M
Funding Rounds
Not tracked yet 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet RNA-targeted Therapies, LNA-based Drug Development, Biopharmaceutical, Clinical-stage Company, Infectious Diseases, Cardiometabolic Disorders, Drug Discovery, Pharmaceutical Partnerships, MiRNA Therapeutics, Patent Estate, Danish Biotech, US Operations
Website
bostonbiomedical.com santaris.com
Boston Biomedical, Inc. logo

About Boston Biomedical, Inc.

Boston Biomedical, Inc. is a leading developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The company, founded in 2006, is a fully integrated oncology drug research and development company with a track record of accomplishments in advancing the research a...

Santaris Pharma logo

About Santaris Pharma

Santaris Pharma is a clinical-stage biopharmaceutical company founded in 2003, headquartered in Denmark, and operating in the United States. The company specializes in pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse disease states. Santaris Pharma's proprietary LN...

We will tell you when either one moves

BounceWatch watches Boston Biomedical, Inc. and Santaris Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Boston Biomedical, Inc... and Santaris Pharma — by email.

Frequently Asked Questions

Boston Biomedical, Inc.. Santaris Pharma — Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse disease states.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Boston Biomedical, Inc. has raised undisclosed funding while Santaris Pharma has raised $72.40M.
Boston Biomedical, Inc. and Santaris Pharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Boston Biomedical, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Santaris Pharma on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes